Albano Laziale, Italy

Nicola Cazzolla

This inventor holds 36 USPTO granted patents and 1 published patent application, plus 12 CIPO patents and 21 EPO patents, primarily in Indazole Compounds. Top assignee: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.. Active years: 2001-2018.

USPTO Granted Patents = 36 

% Patents Active = 16.7


 

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Ariccia, IT (2001)
  • Abano Laziale, IT (2013)
  • Rome, IT (2016 - 2017)
  • Albano Laziale, IT (2009 - 2018)

Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Indazole Compounds
Glycogen Synthase Kinase
Analgesic Activity
Pharmaceutical Formulation
Serotoninergic Agents
Cationic Polymers
Neuropathic Pain
Aminocarbazole Compounds
Tricyclic Indazole
Drug Formulation
Indole Derivatives
Disease Treatment
36 patents (USPTO):Explore Patents

Title: The Innovations of Nicola Cazzolla

Introduction

Nicola Cazzolla, based in Albano Laziale, Italy, is an accomplished inventor with a remarkable portfolio of 36 patents. His innovative contributions primarily focus on pharmaceuticals, particularly in developing compounds that target critical health issues. Cazzolla's work is noteworthy for its potential impact on treating a wide range of disorders.

Latest Patents

Among his most recent patents, one stands out: the invention of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta (GSK-3β) inhibitors. This innovation addresses GSK-3β-related disorders, including insulin resistance, neurodegenerative diseases, mood disorders, schizophrenia, cancer, inflammation, substance abuse, epilepsy, and neuropathic pain. Another significant patent is for a 3-aminocarbazole compound, which includes a pharmaceutical composition containing it and a method for its preparation. This invention aims at providing a drug useful in treating disturbances linked to the production of prostaglandin E (PGE), addressing inflammatory processes, pain, fever, tumors, Alzheimer's disease, and atherosclerosis.

Career Highlights

Cazzolla has built a distinguished career working with prominent companies such as Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a. His extensive experience and innovative research have established him as a notable figure in the pharmaceutical field.

Collaborations

Throughout his career, Nicola has collaborated with esteemed professionals in the industry, including Guido Furlotti and Maria Alessandra Alisi. These partnerships have likely enhanced the development and commercialization of his groundbreaking inventions, contributing to advancements in medical treatments.

Conclusion

Nicola Cazzolla's contributions to the field of pharmaceuticals through his numerous patents exemplify his commitment to innovation and improvement in healthcare. With a focus on addressing complex health issues, his work remains influential and significant for both patients and the medical community. As he continues to advance his research, Cazzolla’s inventions will undoubtedly play a vital role in shaping the future of medical treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…